This longer duration of action allows EYLEA to be administered every 4-8 weeks, reducing treatment burden compared to monthly injections needed with ranibizumab and bevacizumab. https://www.coherentmi.com/blog/global-eylea-drug-a-breakthrough-in-treatment-of-retinal-diseases-60